Urs Hüttemann
About Urs Hüttemann
Urs Hüttemann serves as the Hybrid Therapies Sales Manager for EMEA at AtriCure, Inc., a position he has held since 2021. He has extensive experience in the medical device industry, having previously worked in key roles at CardioFocus, St. Jude Medical, and Johnson & Johnson.
Work at AtriCure
Urs Hüttemann serves as the Hybrid Therapies Sales Manager for the EMEA region at AtriCure, Inc. He has held this position since 2021. His role involves overseeing sales strategies and initiatives related to hybrid therapies, contributing to the company's growth and market presence in Europe, the Middle East, and Africa. Hüttemann's experience in the medical device industry supports his efforts in driving sales and building relationships with healthcare professionals.
Previous Experience at CardioFocus
Prior to joining AtriCure, Urs Hüttemann worked at CardioFocus as a Key Account Manager from 2019 to 2021. In this role, he was responsible for managing key client relationships and driving sales growth in the German market. His tenure at CardioFocus provided him with valuable insights into the cardiac treatment landscape.
Experience at St. Jude Medical
Urs Hüttemann was employed at St. Jude Medical as a Business Development Manager in the Structural Heart Division for one year, from 2012 to 2013. His responsibilities included identifying business opportunities and developing strategies to enhance the company's offerings in the structural heart market.
Career at Johnson & Johnson
From 2014 to 2019, Urs Hüttemann worked at Johnson & Johnson, specifically in the Biosense Webster division, as a Market Development Manager for Left Atrial Appendage (LAA) products. His role involved market analysis and development strategies to promote LAA solutions in Düsseldorf and surrounding areas in Germany.
Education and Expertise
Urs Hüttemann possesses a strong background in sales and business development within the medical device sector. His expertise spans various aspects of market development, account management, and strategic planning, particularly in the fields of cardiac therapies and structural heart solutions.